We have experience in applying this platform of analyses to rats and mice, but many of the tests can be equally applied to other species of interest. We have also experience in cats, rabbits, non-human primates and human postmortem tissue. This platform can be a useful tool for determining the overall impact of a certain pharmacological compound or to evaluate its effects on an animal model of a certain psychiatric disorder.

We are currently offering analyses in different models of major depression and schizophrenia. Neuromov can also be used to evaluate neural plasticity in transgenic animals, on which we have also experience in applying these analyses.